There is an increasing need for early and accurate screening for Alzheimer's Disease (AD) and Amnestic Mild Cognitive Impairment (aMCI). Machine learning applied to spontaneous speech is emerging as a promising, cost-effective, and rapid screening method. However, machine learning methods such as artificial neural networks are often challenging for clinicians to interpret.
The classifier registered an accuracy of approximately 95.42%, with a sensitivity of 96.63% for aMCI/AD and a specificity of 93.75% for HC.